These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9951335)

  • 21. [Norman epidemics: MenBvac vaccine].
    Floret D
    Arch Pediatr; 2007 Jun; 14(6):541-3. PubMed ID: 17446054
    [No Abstract]   [Full Text] [Related]  

  • 22. [Results of a study on the under-detection of meningococcus in vaccinated subjects in Galicia].
    Malvar Pintos A
    Rev Esp Salud Publica; 2000; 74(4):381-6. PubMed ID: 11031847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mode of splenectomy and immunogenicity of meningococcal vaccination in patients with hereditary spherocytosis.
    Stoehr GA; Luecken J; Zielen S; Eber SW; Borrow R; Rose MA
    Br J Surg; 2008 Apr; 95(4):466-71. PubMed ID: 18161897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of serogroup on the presentation, course, and outcome of invasive meningococcal disease in children in the Republic of Ireland, 1995-2000.
    Healy CM; Butler KM; Smith EO; Hensey OP; Bate T; Moloney AC; MacMahon P; Cosgrove J; Cafferkey MT
    Clin Infect Dis; 2002 May; 34(10):1323-30. PubMed ID: 11981727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis.
    De Wals P; Coudeville L; Trottier P; Chevat C; Erickson LJ; Nguyen VH
    Vaccine; 2007 Jul; 25(29):5433-40. PubMed ID: 17560695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Were the meningococcal vaccination campaigns in 1974-76 of benefit?].
    Peltola H; Nors T; Salminen S; Käyhty H; Sivonen A; Jousimies-Somer H; Mäkelä P
    Duodecim; 1983; 99(5):332-41. PubMed ID: 6872895
    [No Abstract]   [Full Text] [Related]  

  • 27. [Meningococcal disease. The situation in Spain in the 1998-1999 period].
    Cano Portero R; García Delgado C; de Mateo Ontañón S
    Rev Esp Salud Publica; 2000; 74(4):369-75. PubMed ID: 11031845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Susceptibility to antimicrobial drugs used in the prophylaxis of meningococcal disease: situation after an epidemic wave].
    Arreaza L; de la Fuente L; Fernández S; Vázquez JA
    Rev Esp Quimioter; 2000 Jun; 13(2):182-6. PubMed ID: 10918092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of a serologic study after vaccination against serogroup C Neisseria meningitidis in children].
    Espín Ríos MI
    Rev Esp Salud Publica; 2000; 74(4):445-8. PubMed ID: 11031855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis.
    Zonneveld-Huijssoon E; Ronaghy A; Van Rossum MA; Rijkers GT; van der Klis FR; Sanders EA; Vermeer-De Bondt PE; Hoes AW; van der Net JJ; Engels C; Kuis W; Prakken BJ; Van Tol MJ; Wulffraat NM
    Arthritis Rheum; 2007 Feb; 56(2):639-46. PubMed ID: 17265499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evolution of meningococcal infection among infant population in the autonomous community of Valencia (1996-2000). Effectiveness of A+C meningococcal vaccination].
    Goicoechea Sáez M; Fullana Montoro AM; Momparler Carrasco P; Redondo Gallego MJ; Brines Solanes J; Bueno Cañigral FJ
    Rev Esp Salud Publica; 2003; 77(1):125-42. PubMed ID: 12696392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The first effect of the national vaccination campaign against meningococcal-C disease: a rapid and sharp decrease in the number of patients].
    de Greeff SC; de Melker HE; Spanjaard L; van den Hof S; Dankert J
    Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1132-5. PubMed ID: 12822525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002.
    Raghunathan PL; Jones JD; Tiendrebéogo SR; Sanou I; Sangaré L; Kouanda S; Dabal M; Lingani C; Elie CM; Johnson S; Ari M; Martinez J; Chatt J; Sidibe K; Schmink S; Mayer LW; Kondé MK; Djingarey MH; Popovic T; Plikaytis BD; Carlone GM; Rosenstein N; Soriano-Gabarró M
    J Infect Dis; 2006 Mar; 193(5):607-16. PubMed ID: 16453255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei City, China.
    Ni JD; Jin YH; Dai B; Wang XP; Liu DQ; Chen X; Zheng Y; Ye DQ
    Postgrad Med J; 2008 Feb; 84(988):87-92. PubMed ID: 18322129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making.
    Welte R; van den Dobbelsteen G; Bos JM; de Melker H; van Alphen L; Spanjaard L; Rümke HC; Postma MJ
    Vaccine; 2004 Dec; 23(4):470-9. PubMed ID: 15530695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Situation of the epidemic strain C:2b:P1.2,5 of Neisseria meningitidis after A+C vaccination].
    Alcalá Galicia B; Vázquez Moreno JA
    Rev Esp Salud Publica; 2000; 74(4):377-9. PubMed ID: 11031846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MeNZB vaccine and epidemic control: when do you stop vaccinating?
    Loring BJ; Turner N; Petousis-Harris H
    Vaccine; 2008 Nov; 26(47):5899-904. PubMed ID: 18804134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of antibodies against rubella virus in Spain.
    Eiros Bouza JM; Luquero Alcalde FJ; Castrodeza Sanz JJ; Bachiller Luque MR; de Lejarazu Leonardo RO
    Clin Infect Dis; 2007 Feb; 44(3):465-6. PubMed ID: 17205464
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the epidemic of acute meningococcosis in Belgium. Study of 60 patients and their families (1972-1973)].
    Linz R; Lecocq E; Custermans L; Lejour M; Mommens M
    Arch Belg Med Soc; 1973; 31(9):569-87. PubMed ID: 4791021
    [No Abstract]   [Full Text] [Related]  

  • 40. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation.
    Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
    Clin Infect Dis; 2007 Mar; 44(5):625-34. PubMed ID: 17278051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.